Chevy Chase Trust Holdings, Inc. Biogen Inc. Transaction History
Chevy Chase Trust Holdings, Inc.
- $32.3 Billion
- Q4 2024
A detailed history of Chevy Chase Trust Holdings, Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Chevy Chase Trust Holdings, Inc. holds 76,820 shares of BIIB stock, worth $10.7 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
76,820
Previous 78,625
2.3%
Holding current value
$10.7 Million
Previous $15.2 Million
22.92%
% of portfolio
0.04%
Previous 0.05%
Shares
31 transactions
Others Institutions Holding BIIB
# of Institutions
1,000Shares Held
131MCall Options Held
1.77MPut Options Held
2.34M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2.34 Billion0.05% of portfolio
-
Primecap Management CO Pasadena, CA16MShares$2.24 Billion1.94% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.03 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.4MShares$1.03 Billion0.05% of portfolio
-
Wellington Management Group LLP Boston, MA4.93MShares$690 Million0.14% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $20.1B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...